Mary Di Biase X4 Pharmaceuticals, Inc (XFOR) insider trading activity
Mary Di Biase is Chief Operating Officer of X4 Pharmaceuticals, Inc. Currently has a direct ownership of 291,752 shares of XFOR, which is worth approximately $280,081. The most recent transaction as insider was on Mar 11, 2024, when has been sold 15,409 shares (Common Stock) at a price of $0.88 per share, resulting in proceeds of $13,559. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
292K
0%
3M change
93.21%
12M change
Total Value Held
$280,081
Mary DiBiase Transaction History
MD
Mary Di Biase
Chief Operating Officer
Boston, MA